Avalo Therapeutics, Inc. · NASDAQ:AVTX

Ra Capital Management, L.P. reported a 9.90% stake in Avalo Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

Ra Capital Management, L.P. reported a 9.90% stake in Avalo Therapeutics, Inc., 2,455,655 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
9.90%
Shares
2,455,655
Intent
Passive
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
RA Capital Management, L.P.9.90%2,455,655
Peter Kolchinsky9.90%2,455,655
Rajeev Shah9.90%2,455,655
RA Capital Healthcare Fund, L.P.9.90%2,455,655

Source

View original at SEC

Related